These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28705022)

  • 1. Evaluation of dose and outcomes for pediatric vilazodone ingestions.
    Gaw CE; Spiller HA; Russell JL; Chounthirath T; Smith GA
    Clin Toxicol (Phila); 2018 Feb; 56(2):113-119. PubMed ID: 28705022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
    Russell JL; Spiller HA; Chounthirath T; Casavant MJ
    Clin Toxicol (Phila); 2017 Jun; 55(5):352-356. PubMed ID: 28421837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vilazodone poisoning: a systematic review.
    Baumgartner K; Doering M; Schwarz E
    Clin Toxicol (Phila); 2020 May; 58(5):360-367. PubMed ID: 31777303
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of vilazodone exposures with focus on serotonin syndrome effects.
    Heise CW; Malashock H; Brooks DE
    Clin Toxicol (Phila); 2017 Nov; 55(9):1004-1007. PubMed ID: 28594246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures After Pediatric Vilazodone Ingestion: A Case Series.
    Del Pizzo J; Fernandez EK; Kopec KT; Wenger J; Noyes EM; Salzman M; Henretig FM
    Pediatr Emerg Care; 2018 Mar; 34(3):e51-e54. PubMed ID: 28590988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children.
    Klein-Schwartz W; Benson BE; Lee SC; Litovitz T
    Clin Toxicol (Phila); 2012 Jun; 50(5):418-23. PubMed ID: 22506805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Vilazodone Toxicity in a Pediatric Patient.
    Acker EC; Sinclair EA; Beardsley AL; Ahmed SS; Froberg BA
    J Emerg Med; 2015 Sep; 49(3):284-6. PubMed ID: 26099909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of acute exploratory pediatric lithium ingestions.
    Minhaj FS; Anderson BD; King JD; Leonard JB
    Clin Toxicol (Phila); 2020 Sep; 58(9):881-885. PubMed ID: 31913731
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of severe serotonin syndrome from acute ingestion of vilazodone without co-ingestion.
    Clevenger J; McCabe D
    Am J Emerg Med; 2020 May; 38(5):1045.e1-1045.e2. PubMed ID: 31902699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin Syndrome in a Pediatric Patient After Vilazodone Ingestion.
    Laliberte B; Kishk OA
    Pediatr Emerg Care; 2018 Dec; 34(12):e226-e228. PubMed ID: 28350718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vilazodone, a Selective Serotonin Reuptake Inhibitor with Diminished Impact on Methylphenidate-Induced Gene Regulation in the Striatum: Role of 5-HT1A Receptor.
    Hrabak M; Moon C; Bolaños-Guzmán CA; Steiner H
    Mol Neurobiol; 2024 Apr; 61(4):1907-1919. PubMed ID: 37807008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough seizures after starting vilazodone for depression.
    McKean J; Watts H; Mokszycki R
    Pharmacotherapy; 2015 Mar; 35(3):e6-8. PubMed ID: 25809181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin Syndrome Associated With Vilazodone Overdose in a 22-Month-Old Treated With Dexmedetomidine.
    Schlichting E; Welter C; Schaeffer T; Strout TD
    J Emerg Med; 2021 Feb; 60(2):e19-e21. PubMed ID: 33158691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to United States poison centers.
    Mazer-Amirshahi M; Reid N; van den Anker J; Litovitz T
    J Pediatr; 2013 Nov; 163(5):1372-6. PubMed ID: 23769500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.
    Nelson LS; Erdman AR; Booze LL; Cobaugh DJ; Chyka PA; Woolf AD; Scharman EJ; Wax PM; Manoguerra AS; Christianson G; Caravati EM; Troutman WG
    Clin Toxicol (Phila); 2007 May; 45(4):315-32. PubMed ID: 17486478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of prescription psychotropic medication exposures in pediatric patients, 2009-2018.
    Hunter K; Poel K; Pennington S; Bindseil I; Banerji S; Leonard J; Wang GS
    Clin Toxicol (Phila); 2022 Feb; 60(2):243-251. PubMed ID: 34196239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.
    Dawson LA; Watson JM
    CNS Neurosci Ther; 2009; 15(2):107-17. PubMed ID: 19499624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected tricyclic antidepressant ingestions involving children 6 years old or less.
    McFee RB; Caraccio TR; Mofenson HC
    Acad Emerg Med; 2001 Feb; 8(2):139-44. PubMed ID: 11157289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant exposures associated with exploratory behavior among young children reported to United States poison control centers, 2000-2020.
    Francis M; Spiller HA; Badeti J; Casavant MJ; Michaels NL; Zhu M; Smith GA
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1206-1216. PubMed ID: 35999648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.